Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer

Clinical trial NCT07153055 · RECRUITING

Trial details

NCT number: NCT07153055
Sponsor: Misty Shields
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer ( SCLC )Transformed Small Cell Lung Cancer

Start date: 2026-08-01
Primary completion: 2029-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.